Influenza Immunization for Children With Bronchopulmonary Dysplasia in Poland

Brydak, Lidia B.; B, Fracka; Marusak, Maria; Rudnicka, H; Nachman, Sharon

doi:10.1097/00006454-199705000-00028

Cited by 11 publications

(4 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In 1991, Groothuis et al35) reported that, in 113 children with BPD or congenital heart disease aged 3-18 months, mild adverse reactions were reported in 6%-14% of cases, and two-dose vaccination was required in order to achieve four-fold seroconversion. In a 1998 clinical report, Brydak et al36) reported that six infants with BPD aged 8-21 months who received two doses of 0.25 mL of the trivalent split influenza vaccine showed a high-fold increase in geometric mean titers. Since 1990, numerous studies on split or subunit influenza vaccines for children with asthma showed no difference in immunogenicity against A antigens between asthma patients and healthy children, whereas in the case of B antigens, asthma patients had slightly lower immunogenicity than healthy children37).…”

Section: Studies Of the Safety And Efficacy Of Inactivated Influenza mentioning

confidence: 99%

Effectiveness and safety of seasonal influenza vaccination in children with underlying respiratory diseases and allergy

Kang

2014

Korean J Pediatr

View full text Add to dashboard Cite

Influenza causes acute respiratory infections and various complications. Children in the high-risk group have higher complication and hospitalization rates than high-risk elderly individuals. Influenza prevention in children is important, as they can be a source infection spread in their communities. Influenza vaccination is strongly recommended for high-risk children with chronic underlying circulatory and respiratory disease, immature infants, and children receiving long-term immunosuppressant treatment or aspirin. However, vaccination rates in these children are low because of concerns regarding the exacerbation of underlying diseases and vaccine efficacy. To address these concerns, many clinical studies on children with underlying respiratory diseases have been conducted since the 1970s. Most of these reported no differences in immunogenicity or adverse reactions between healthy children and those with underlying respiratory diseases and no adverse effects of the influenza vaccine on the disease course. Further to these studies, the inactivated split-virus influenza vaccine is recommended for children with underlying respiratory disease, in many countries. However, the live-attenuated influenza vaccine (LAIV) is not recommended for children younger than 5 years with asthma or recurrent wheezing. Influenza vaccination is contraindicated in patients with severe allergies to egg, chicken, or feathers, because egg-cultivated influenza vaccines may contain ovalbumin. There has been no recent report of serious adverse events after influenza vaccination in children with egg allergy. However, many experts recommend the trivalent influenza vaccine for patients with severe egg allergy, with close observation for 30 minutes after vaccination. LAIV is still not recommended for patients with asthma or egg allergy.

show abstract

Section: Studies Of the Safety And Efficacy Of Inactivated Influenza mentioning

confidence: 99%

Effectiveness and safety of seasonal influenza vaccination in children with underlying respiratory diseases and allergy

Kang

2014

Korean J Pediatr

View full text Add to dashboard Cite

show abstract

“…Children aged 6-35 months, 3-8 years, 9-12 years, 0.13-20 years (Brydak, 2004) Children with acute lymphoblastic leukemia (ALL), vaccinated at different times after treatment (Brydak et al, 1998a(Brydak et al, ,b, 1997c Children with severe hemophilia (Brydak et al, 1998a,b) Children with bronchopulmonary dysplasia (Brydak et al, 1997b) Children with glomerulonephritis (Brydak et al, 2000) Children with chronic renal failure subjected to continuous ambulatory peritoneal dialysis, hemodialysis, and chronic renal failure vaccinated once and twice (Brydak et al, 2001b) Children infected with HIV Children vaccinated after splenectomy in age groups 0-5 years, 6-10 years, 11-15 years (Brydak et al, 2004a,b) Children with aplastic anemia, children with bronchial asthma, children with inflammatory bowel disease (Brydak, 2008) Adults Adults aged 21-30, 31-40, 41-50, 51-64, >64 years (Brydak et al, 200321-30, 31-40, 41-50, 51-64, >64 years (Brydak et al, , 2004b Billeted students of the Military Medical Academy (Brydak et al, 1997a) Patients with acute lymphoblastic leukemia (Brydak and Calbecka, 1999) Patients with chronic renal failure (Koziol-Montewka et al,…”

Section: Childrenmentioning

confidence: 99%

Influenza diagnosis and vaccination in Poland

Brydak

Woźniak-Kosek

Nitsch–Osuch

2013

Respiratory Physiology & Neurobiology

View full text Add to dashboard Cite

In Poland between several thousand and several million cases of influenza and suspected influenza cases are registered, depending on the epidemic season. A variety of methods are available for the detection of the influenza viruses responsible for respiratory infection starting with the isolation of the virus in chick embryos or in cell lines such as MDCK, VERO, etc., and finishing with a variety of modifications of the classical PCR molecular biology such as PCR multiplex and Real-Time. The most effective way to combat influenza is through vaccination. Regular vaccination is one of the few steps that may be taken to protect individuals, especially in high-risk groups, from the potential and serious complications of influenza. In many countries, including Poland, despite the recommendations, the rate of vaccination against influenza is still low in all age groups. In the epidemic season 2011/2012, the level of distribution of the seasonal influenza vaccines was 4.5% of the population.

show abstract

“…Children suffering from BPD are particularly at risk during the influenza season. The aim of these investigations was to assess the humoral response to influenza vaccine in children with BPD immunized in two consecutive epidemic seasons 1995/96 and 1996/97.The study group consisted of six preterm children (their gestational age varied from 25 to 30 weeks) with BPD who had previously been vaccinated with a double 0.25 ml dose of split influenza vaccine ("Fluarix", SmithKline Beecham) in autumn 1995 [2]. In 1996 the same group of patients was repeatedly vaccinated and received a single 0.25 ml dose of the same kind of vaccine ("Vaxigrip", Pasteur Mérieux).…”

Section: Antibody Response To Influenza Vaccine In Children With Bronmentioning

confidence: 99%

“…In 1996 the same group of patients was repeatedly vaccinated and received a single 0.25 ml dose of the same kind of vaccine ("Vaxigrip", Pasteur Mérieux). Anti-hemagglutinin (HI) and anti-neuraminidase (NI) antibody levels were determined before immunization and 4 weeks (in 1995/96) or 3 weeks (in 1996/97) after the second dose of vaccine was given [2]. The hemagglutinin inhibition test and neuraminidase inhibition test were used.…”

Section: Antibody Response To Influenza Vaccine In Children With Bronmentioning

confidence: 99%

Antibody Response to Influenza Vaccine in Children with Bronchopulmonary Dysplasia

Brydak¹,

B²,

Machała³

et al. 2001

Infection

View full text Add to dashboard Cite

Influenza Immunization for Children With Bronchopulmonary Dysplasia in Poland

Cited by 11 publications

References 4 publications

Effectiveness and safety of seasonal influenza vaccination in children with underlying respiratory diseases and allergy

Effectiveness and safety of seasonal influenza vaccination in children with underlying respiratory diseases and allergy

Influenza diagnosis and vaccination in Poland

Antibody Response to Influenza Vaccine in Children with Bronchopulmonary Dysplasia

Contact Info

Product

Resources

About